Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin 340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements - (Posted On Wednesday, July 07, 2021) 340B Update: Federal Court Halts 340B Administrative Dispute Resolution Rule - (Posted On Monday, March 29, 2021) Hospitals Ask Supreme Court to Reverse Site-Neutral, 340B Payment Rulings - (Posted On Thursday, March 25, 2021) 340B Drug Pricing Program 2021 Outlook [PODCAST] - (Posted On Friday, March 19, 2021) COVID-19: Reimbursement Corner: Graduate Medical Education Gets Major Boost From Congressional Appropriations Bill - (Posted On Wednesday, December 23, 2020) 340B Update: HRSA Moves Forward with 340B ADR Rule as Covered Entities Challenge Contract Pharmacy Actions [PODCAST] - (Posted On Thursday, December 03, 2020) OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees - (Posted On Wednesday, December 02, 2020) 340B Update: Ryan White Clinics Sue in Response to Contract Pharmacy Actions as Congress Requests Information on Ways to Improve the 340B Program - (Posted On Friday, October 16, 2020) CMS'S Proposed Phase-Out of the Inpatient Only List is not Entirely Welcome News - (Posted On Tuesday, September 29, 2020) 340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions - (Posted On Saturday, September 26, 2020) Pagination Previous page ‹ Previous Page 2 Next page Next › Current Legal Analysis The ‘Lifeline’ of Chapter 11: Understanding DIP Financing by: Financial Poise Faculty Demystifying Discovery: What You Need To Know by: Joshua L. Gablin Choosing, Building, and Protecting Your Brand by: Michele Schechter San Diego ADU Incentive Rollback Sheds Light on California Housing Woes by: Brooke Miller Victoria's New Developer Bond Scheme: Implications for Developers by: Will Grinter , Maddy Bassal APHIS Seeks Comment on Petitions to Deregulate Orchid Developed Using Genetic Engineering by: Lynn L. Bergeson , Carla N. Hutton With the NLRB Unable To Decide Cases, States Move to Fill the Void (US) by: Labor and Employment Practice Group Squire Patton Boggs First Six Months of the Trump Administration — A Conversation with James V. Aidala [Podcast] by: Lynn L. Bergeson UPDATE: LWDA Not Liable for Costs in PAGA Action by: Timothy Long , Oscar E. Peralta OECD Publishes Report on Commercial Availability and Current Uses of PFAS and Alternatives in Hydraulic Oils and Lubricants by: Lynn L. Bergeson , Carla N. Hutton CIPA LITIGATION RISK CONTINUES!: Senate Bill 690 – Exempting Website Tracking Technologies From California’s Wiretap Law – Moves Forward As A Two-Year Bill, Potentially Carrying Over Into The 2026 Legislative Session by: Tammana Malik Virginia Expands Definition of ‘Low-Wage’ Employees and Noncompetes by: Nicholas D. SanFilippo , Shirin Afsous EP Research Service Publishes Think Tank Briefing on EU Chemicals Strategy for Sustainability by: Lynn L. Bergeson , Carla N. Hutton National Coal Council Reinstated by Executive Order by: Frederick R. Eames , Joanna D. Enns California Appellate Court Affirms Employer’s Decertification of Meal and Rest Period Class Action by: Spencer C. Skeen , Zachary V. Zagger Upcoming Events Jul 2 2025 Top Tips for Employers – Drug Testing Policies, Administration, & Litigation Jul 8 2025 Environmental Essentials Webinar - EPA’s Proposed Repeal of the Carbon Pollution Standards for Power Plants: Implications for the Rest of Industry Jul 9 2025 Employment Law in the US Jul 10 2025 Mandatory Roth Catch-up Print
